|
Alemtuzumab
|
Visite: 214
|
|
Altretamine
|
Visite: 412
|
|
Aminoglutetimide
|
Visite: 369
|
|
L'Acido 5-Aminolevulinico
|
Visite: 320
|
|
Idrossicarbamide
|
Visite: 226
|
|
Anastrozole
|
Visite: 388
|
|
Arsenico Triossido Di
|
Visite: 386
|
|
Asparaginasi
|
Visite: 344
|
|
Bevacizumab
|
Visite: 250
|
|
Bexarotene
|
Visite: 394
|
|
Bleomicina
|
Visite: 383
|
|
Busulfan
|
Visite: 350
|
|
Capecitabina
|
Visite: 361
|
|
Carboplatino
|
Visite: 414
|
|
Carmustina
|
Visite: 408
|
|
Cetuximab
|
Visite: 261
|
|
Ciclofosfamide
|
Visite: 379
|
|
Cisplatino
|
Visite: 250
|
|
La citarabina
|
Visite: 237
|
|
Cladribina
|
Visite: 248
|
|
Chlorambucil
|
Visite: 383
|
|
Chlormethinum
|
Visite: 514
|
|
Dacarbazina
|
Visite: 200
|
|
Dactinomicina
|
Visite: 262
|
|
Daunorubicina
|
Visite: 213
|
|
Docetaxel
|
Visite: 199
|
|
Doxorubicina
|
Visite: 417
|
|
Epirubucin
|
Visite: 208
|
|
Erlotinib
|
Visite: 332
|
|
Etoposide
|
Visite: 256
|
|
Exemestano
|
Visite: 406
|
|
Fluorouracile Topico Soluzione
|
Visite: 187
|
|
Fluorouracile
|
Visite: 261
|
|
Gemcitabina
|
Visite: 194
|
|
Idarubicina-Hcl
|
Visite: 357
|
|
Ifosfamide
|
Visite: 221
|
|
Melfalan
|
Visite: 194
|
|
Mercaptopurina
|
Visite: 336
|
|
Methotrexate
|
Visite: 291
|
|
Mitomicina
|
Visite: 304
|
|
Mitoxantrone
|
Visite: 187
|
|
Oxaliplatino
|
Visite: 175
|
|
Paclitaxel
|
Visite: 230
|
|
Pentostatina
|
Visite: 241
|
|
Procarbazina
|
Visite: 234
|
|
Rituximab
|
Visite: 262
|
|
Teniposide
|
Visite: 196
|
|
Tioguanina
|
Visite: 181
|
|
Tiotepa
|
Visite: 192
|
|
Trastuzumab
|
Visite: 249
|
|
Tretinoin Orale
|
Visite: 375
|
|
Vinblastina
|
Visite: 200
|
|
Vincristina
|
Visite: 192
|
|
Vinorelbine Tartrate
|
Visite: 222
|
|
Everolimus
|
Visite: 224
|
|
Imatinib Mesilato
|
Visite: 209
|
|
Nilotinib
|
Visite: 255
|
|
Dasatinib
|
Visite: 216
|
|
Pazopanib
|
Visite: 190
|
|
Ipilimumab
|
Visite: 192
|
|
Nivolumab
|
Visite: 228
|
|
Brentuximab Vedotin
|
Visite: 219
|